Development of predictive pharmacokinetic simulation models for drug discovery
- 25 February 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 65 (1-2) , 55-62
- https://doi.org/10.1016/s0168-3659(99)00232-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Managing the drug discovery/development interfaceDrug Discovery Today, 1997
- Simulation models to predict oral drug absorption from in vitro dataAdvanced Drug Delivery Reviews, 1997
- Novel Approach to the Analysis of in Vitro–in Vivo Relationships**Presented in part at the Ninth Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists, San Diego, CA, November 1994.Journal of Pharmaceutical Sciences, 1996
- Effect of Food on the Relative Bioavailability of Oral GanciclovirThe Journal of Clinical Pharmacology, 1996
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patientsClinical Therapeutics, 1995
- Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II StudyThe Journal of Infectious Diseases, 1995
- In Vitro Dissolution Tests Corresponding to the in Vivo Dissolution of Clarithromycin Tablets in the Stomach and Intestine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Absorption Potential: Estimating the Fraction Absorbed for Orally Administered CompoundsJournal of Pharmaceutical Sciences, 1985
- Pharmacokinetic studies with atenolol in the dogBiopharmaceutics & Drug Disposition, 1983